Skip to search formSkip to main contentSkip to account menu

rucaparib 200 MG Oral Tablet [Rubraca]

Known as: Rubraca (as rucaparib camisylate) 200 MG Oral Tablet, Rubraca 200 MG Oral Tablet, rucaparib camsylate 200 mg ORAL TABLET, FILM COATED [Rubraca] 
National Institutes of Health

Related topics

Related topics

13 relations
Brilliant blue FCFIndigo CarmineMagnesium stearateOral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Rucaparip (Rubraca®) induces necrosis via upregulating the expression of RIP1 and RIP3 in ovarian cancer cells.
In the current study we investigated the inhibitory effect of rucaparib (Rubraca®) on human ovarian cancer SKOV3 and A2780 cells… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)